About Us
At Resonance Biotechnology, we harness the groundbreaking potential of Surface Plasmon-Coupled Emission (SPCE) to advance high-throughput screening in Drug Discovery. Our SPCE technology redefines the standards of fluorescence detection sensitivity, paving the way for transformative advancements in the detection of biomolecular interactions. Surpassing traditional Surface Plasmon Resonance (SPR) techniques, our approach is meticulously designed to excel in high-throughput screening environments, boasting the extraordinary capability to discern single-molecule events. We invite you to join us on our journey to redefine the biotechnological landscape, as we strive to enhance diagnostic and research methodologies with unprecedented efficiency and accuracy, setting new benchmarks for field of drug discovery.
Unmatched Precision
SPCE provides an unprecedented level of precision and accuracy in the analysis of biological samples. By leveraging this technology, we are able to uncover insights that were previously impossible to detect.
Platform Technology
SPCE is a platform technology that revolutionizes biosensing with its versatility in application, effectively streamlining the detection of biomolecular interactions for rapid advancements in drug discovery and diagnostics.
High-Throughput Screening
SPCE enhances high-throughput screening by providing a sophisticated platform for detailed analysis of biomolecular interactions, significantly improving the efficiency and accuracy of drug discovery processes.
World-Class Team
Our team at Resonance Biotechnology is a beacon of excellence, boasting over 100 years of combined experience in fluorescence research and 20+ years in pioneering SPCE technology. This unparalleled expertise fuels our leadership in the industry, driving innovation and setting new standards in biotech.
"Our Laboratory at TCU is one of the best equipped laboratories for time-resolved fluorescence spectroscopy in the world. Our global collaborations with leading institutions continually enhance our research and capabilities."
Driven By excellence,
Defined by Results.
Our dedication to precision has set new benchmarks in the realm of biological sample scanning. With our state-of-the-art SPCE technology at the forefront, we are poised to revolutionize the field of drug discovery. Our vision for the future is a world where insights are deeper, discoveries are more profound, and the boundaries of biotechnology are continually expanded.
The Resonance Biotechnology Advantage
20+
Years of Development
50%
Cost Reduction compared to conventional methods
800+
Samples Analyzed
1000x
More precise than leading competitors
3
Industry-Defining Breakthroughs
Meet the Team
Co-founder and Chief Executive Officer
Rajveer Singh Sagoo
Co-Founder and Clinical Lead
Navraj Sagoo, MD
Chief Scientific Officer
Zygmunt Gryczynski, PhD
Chief Scientific Officer
Ignacy Gryczynski, PhD
Technical Lead
Danh Pham
Strategic Analyst
Bong Lee, PhD
Strategic Analyst
Emma Alexander, PhD